Researchers investigate the potential prognostic predictor of TSB on COVID-19 mortality as well as the demographic and characteristics of this population.
This study sought to determine whether statin initiation for the primary prevention of CVD would improve outcomes.
Researchers conducted a review of patients who were tested for COVID-19 and received aspirin or NSAIDS to assess whether aspirin was protective from death, myocardial infarction, or VTE.
Researchers aimed to study the associations between heart failure medications and certain systemic autoimmune rheumatic diseases.
No significant difference in rates of cardiovascular death and all-cause mortality was noted.
The researchers sought to identify major interaction effects between clopidogrel and CYP2C19*17 status, in terms of risk for MACE and bleeding events after PCI.
Researchers assessed the results of the VICTORIA trial, which included 5048 patients with worsening heart failure, 53.6% of whom had coronary artery disease.
Statins may play an important role in combating inflammation in COVID-19.
The researchers sought to characterize the relationship between inflammatory markers and baseline, maximum, and change in troponin levels.
Researchers evaluated data on clinical outcomes among 107,000 patients from the National Inpatient Sample who had both cancer and atrial fibrillation.